Katerina Kechris
Concepts (503)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 21 | 2026 | 919 | 3.000 |
Why?
| | Metabolomics | 16 | 2024 | 730 | 2.780 |
Why?
| | DNA Methylation | 23 | 2026 | 667 | 2.670 |
Why?
| | Software | 14 | 2026 | 678 | 2.060 |
Why?
| | Algorithms | 14 | 2025 | 1845 | 2.050 |
Why?
| | Genome-Wide Association Study | 11 | 2024 | 1376 | 2.030 |
Why?
| | Computational Biology | 9 | 2025 | 669 | 1.990 |
Why?
| | Gene Expression Profiling | 20 | 2025 | 1763 | 1.760 |
Why?
| | Sequence Analysis, RNA | 9 | 2021 | 442 | 1.690 |
Why?
| | Proteomics | 5 | 2026 | 1185 | 1.690 |
Why?
| | Bayes Theorem | 10 | 2023 | 419 | 1.650 |
Why?
| | MicroRNAs | 11 | 2026 | 686 | 1.650 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2021 | 530 | 1.420 |
Why?
| | Mass Spectrometry | 6 | 2022 | 728 | 1.410 |
Why?
| | Genomics | 7 | 2025 | 819 | 1.350 |
Why?
| | Quantitative Trait Loci | 15 | 2024 | 375 | 1.290 |
Why?
| | Gene Regulatory Networks | 6 | 2025 | 317 | 1.240 |
Why?
| | Gene Expression Regulation | 13 | 2025 | 2588 | 1.210 |
Why?
| | Data Interpretation, Statistical | 5 | 2020 | 368 | 1.170 |
Why?
| | Smoking | 9 | 2025 | 1470 | 1.170 |
Why?
| | Prenatal Exposure Delayed Effects | 13 | 2025 | 650 | 1.130 |
Why?
| | Polymorphism, Single Nucleotide | 11 | 2024 | 2136 | 1.100 |
Why?
| | Autoimmunity | 12 | 2026 | 932 | 1.090 |
Why?
| | Models, Genetic | 7 | 2019 | 523 | 1.050 |
Why?
| | Islets of Langerhans | 9 | 2026 | 846 | 1.040 |
Why?
| | Phenotype | 21 | 2024 | 3138 | 0.960 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2021 | 749 | 0.890 |
Why?
| | Adiposity | 10 | 2024 | 532 | 0.870 |
Why?
| | Diabetes Mellitus, Type 1 | 15 | 2026 | 3918 | 0.820 |
Why?
| | Gene Expression | 10 | 2021 | 1474 | 0.820 |
Why?
| | Brain | 9 | 2024 | 2934 | 0.800 |
Why?
| | Transcriptome | 10 | 2025 | 1029 | 0.780 |
Why?
| | Epigenesis, Genetic | 13 | 2026 | 672 | 0.750 |
Why?
| | Computer Simulation | 9 | 2025 | 1002 | 0.730 |
Why?
| | Metabolome | 5 | 2024 | 387 | 0.730 |
Why?
| | Databases, Factual | 6 | 2021 | 1488 | 0.700 |
Why?
| | Emphysema | 4 | 2023 | 100 | 0.690 |
Why?
| | Models, Statistical | 5 | 2020 | 671 | 0.670 |
Why?
| | Propensity Score | 1 | 2023 | 374 | 0.650 |
Why?
| | Ethanol | 5 | 2020 | 631 | 0.640 |
Why?
| | Maternal Exposure | 6 | 2024 | 188 | 0.630 |
Why?
| | Conserved Sequence | 3 | 2009 | 244 | 0.620 |
Why?
| | Pediatric Obesity | 7 | 2024 | 637 | 0.610 |
Why?
| | Humans | 101 | 2026 | 145140 | 0.610 |
Why?
| | Biomarkers | 21 | 2026 | 4282 | 0.610 |
Why?
| | Pulmonary Emphysema | 6 | 2023 | 277 | 0.600 |
Why?
| | User-Computer Interface | 1 | 2020 | 165 | 0.590 |
Why?
| | Machine Learning | 2 | 2024 | 586 | 0.590 |
Why?
| | Fluorocarbons | 4 | 2023 | 119 | 0.570 |
Why?
| | RNA | 4 | 2021 | 910 | 0.570 |
Why?
| | Fetal Blood | 10 | 2024 | 325 | 0.530 |
Why?
| | Health Status | 1 | 2023 | 832 | 0.520 |
Why?
| | Genetic Predisposition to Disease | 12 | 2025 | 2351 | 0.500 |
Why?
| | Linear Models | 4 | 2019 | 844 | 0.500 |
Why?
| | Female | 68 | 2026 | 78636 | 0.480 |
Why?
| | Models, Theoretical | 1 | 2020 | 556 | 0.480 |
Why?
| | ROC Curve | 5 | 2020 | 617 | 0.480 |
Why?
| | Case-Control Studies | 16 | 2026 | 3616 | 0.470 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 222 | 0.460 |
Why?
| | Alcoholism | 3 | 2020 | 819 | 0.450 |
Why?
| | Animals | 34 | 2023 | 37952 | 0.450 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.440 |
Why?
| | Seroconversion | 3 | 2026 | 48 | 0.440 |
Why?
| | Environmental Pollutants | 3 | 2023 | 138 | 0.430 |
Why?
| | CpG Islands | 7 | 2024 | 161 | 0.430 |
Why?
| | Drosophila | 3 | 2010 | 164 | 0.430 |
Why?
| | Placenta | 5 | 2023 | 784 | 0.410 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.410 |
Why?
| | Pregnancy | 22 | 2025 | 7182 | 0.400 |
Why?
| | Nitrogenase | 2 | 2013 | 11 | 0.400 |
Why?
| | Male | 54 | 2026 | 72664 | 0.390 |
Why?
| | Smoking Cessation | 1 | 2017 | 437 | 0.380 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1454 | 0.380 |
Why?
| | Schistosomiasis japonica | 3 | 2022 | 35 | 0.380 |
Why?
| | Markov Chains | 2 | 2020 | 129 | 0.380 |
Why?
| | Mice | 19 | 2022 | 18303 | 0.370 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1546 | 0.370 |
Why?
| | DNA | 3 | 2019 | 1433 | 0.370 |
Why?
| | Sample Size | 3 | 2023 | 121 | 0.360 |
Why?
| | Genotype | 6 | 2020 | 1844 | 0.360 |
Why?
| | Diabetes, Gestational | 3 | 2023 | 305 | 0.360 |
Why?
| | RNA, Messenger | 7 | 2023 | 2803 | 0.360 |
Why?
| | Child | 31 | 2026 | 22670 | 0.350 |
Why?
| | Transcription Factors | 6 | 2024 | 1731 | 0.350 |
Why?
| | Phylogeny | 2 | 2013 | 917 | 0.350 |
Why?
| | Lipid Metabolism | 4 | 2024 | 529 | 0.340 |
Why?
| | Schistosoma japonicum | 2 | 2022 | 34 | 0.340 |
Why?
| | Child, Preschool | 20 | 2026 | 11835 | 0.330 |
Why?
| | Support Vector Machine | 2 | 2021 | 33 | 0.330 |
Why?
| | Bias | 2 | 2022 | 197 | 0.320 |
Why?
| | Area Under Curve | 3 | 2020 | 329 | 0.320 |
Why?
| | Lung | 5 | 2023 | 4101 | 0.320 |
Why?
| | Genome, Human | 3 | 2019 | 419 | 0.310 |
Why?
| | Molybdoferredoxin | 1 | 2009 | 13 | 0.300 |
Why?
| | Binding Sites | 5 | 2021 | 1309 | 0.300 |
Why?
| | Disease Progression | 6 | 2026 | 2857 | 0.300 |
Why?
| | Autoantibodies | 5 | 2026 | 1508 | 0.290 |
Why?
| | Oxidoreductases | 1 | 2009 | 91 | 0.290 |
Why?
| | Gastrointestinal Tract | 2 | 2022 | 204 | 0.290 |
Why?
| | Infant, Newborn | 15 | 2024 | 6435 | 0.270 |
Why?
| | Adiponectin | 2 | 2024 | 241 | 0.270 |
Why?
| | Mycobacterium tuberculosis | 3 | 2016 | 318 | 0.270 |
Why?
| | Insulin | 6 | 2023 | 2510 | 0.270 |
Why?
| | Cohort Studies | 11 | 2026 | 5988 | 0.270 |
Why?
| | Signal Transduction | 7 | 2020 | 5208 | 0.260 |
Why?
| | Exons | 1 | 2008 | 363 | 0.260 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2021 | 317 | 0.250 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2022 | 638 | 0.250 |
Why?
| | Leukocytes, Mononuclear | 3 | 2015 | 573 | 0.250 |
Why?
| | HIV-1 | 3 | 2022 | 906 | 0.250 |
Why?
| | Cluster Analysis | 3 | 2024 | 500 | 0.250 |
Why?
| | Alternative Splicing | 1 | 2008 | 247 | 0.240 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 182 | 0.240 |
Why?
| | Alcohol Drinking | 5 | 2014 | 836 | 0.230 |
Why?
| | Alkanesulfonic Acids | 2 | 2023 | 34 | 0.220 |
Why?
| | Environmental Exposure | 2 | 2020 | 577 | 0.220 |
Why?
| | Middle Aged | 19 | 2026 | 36126 | 0.220 |
Why?
| | Genome | 3 | 2013 | 304 | 0.220 |
Why?
| | Principal Component Analysis | 2 | 2023 | 191 | 0.220 |
Why?
| | Tuberculosis | 2 | 2020 | 283 | 0.220 |
Why?
| | HIV Infections | 4 | 2022 | 3186 | 0.220 |
Why?
| | Nasal Mucosa | 1 | 2025 | 112 | 0.210 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 127 | 0.210 |
Why?
| | Soot | 1 | 2024 | 23 | 0.210 |
Why?
| | Mice, Inbred Strains | 4 | 2020 | 396 | 0.210 |
Why?
| | Quantitative Trait, Heritable | 3 | 2017 | 113 | 0.210 |
Why?
| | Aged | 14 | 2026 | 26096 | 0.210 |
Why?
| | Oxylipins | 2 | 2023 | 47 | 0.210 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 49 | 0.200 |
Why?
| | Melanocytes | 2 | 2015 | 65 | 0.200 |
Why?
| | Prospective Studies | 9 | 2023 | 8035 | 0.200 |
Why?
| | Severity of Illness Index | 5 | 2021 | 2928 | 0.200 |
Why?
| | Adolescent | 14 | 2026 | 22479 | 0.200 |
Why?
| | Body Mass Index | 5 | 2024 | 2437 | 0.200 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3410 | 0.200 |
Why?
| | Sequence Analysis, DNA | 2 | 2019 | 776 | 0.190 |
Why?
| | Mice, Inbred C57BL | 5 | 2019 | 5972 | 0.190 |
Why?
| | Genetic Association Studies | 3 | 2020 | 367 | 0.190 |
Why?
| | Diet | 2 | 2021 | 1277 | 0.190 |
Why?
| | Genetic Variation | 3 | 2024 | 967 | 0.190 |
Why?
| | Infant | 12 | 2024 | 10060 | 0.190 |
Why?
| | Birth Weight | 3 | 2023 | 513 | 0.180 |
Why?
| | Longitudinal Studies | 7 | 2026 | 2949 | 0.180 |
Why?
| | Vitamin D | 1 | 2026 | 403 | 0.180 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.180 |
Why?
| | Phospholipids | 2 | 2021 | 214 | 0.180 |
Why?
| | Asthma | 2 | 2025 | 1795 | 0.180 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 142 | 0.180 |
Why?
| | Neutrophils | 2 | 2026 | 1123 | 0.180 |
Why?
| | Mothers | 3 | 2023 | 764 | 0.180 |
Why?
| | Schistosomiasis | 1 | 2022 | 50 | 0.180 |
Why?
| | Air Pollutants | 2 | 2024 | 405 | 0.170 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 68 | 0.170 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1138 | 0.170 |
Why?
| | Selection Bias | 1 | 2021 | 38 | 0.170 |
Why?
| | Endemic Diseases | 1 | 2021 | 33 | 0.170 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 63 | 0.170 |
Why?
| | Breast Neoplasms | 3 | 2019 | 2380 | 0.170 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2021 | 33 | 0.170 |
Why?
| | Cloud Computing | 1 | 2021 | 6 | 0.170 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 10 | 0.170 |
Why?
| | Adult | 21 | 2026 | 40665 | 0.170 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 17 | 0.170 |
Why?
| | Immunoglobulin A | 1 | 2022 | 214 | 0.170 |
Why?
| | Central Nervous System Depressants | 2 | 2012 | 84 | 0.170 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1995 | 0.170 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 39 | 0.170 |
Why?
| | Normal Distribution | 2 | 2018 | 22 | 0.160 |
Why?
| | Polyadenylation | 1 | 2021 | 39 | 0.160 |
Why?
| | Mutation | 3 | 2021 | 4071 | 0.160 |
Why?
| | B-Lymphocytes | 1 | 2026 | 866 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 129 | 0.160 |
Why?
| | Population Dynamics | 1 | 2021 | 142 | 0.160 |
Why?
| | Biostatistics | 1 | 2020 | 19 | 0.160 |
Why?
| | Probability | 1 | 2021 | 307 | 0.160 |
Why?
| | Drug Tolerance | 1 | 2020 | 99 | 0.160 |
Why?
| | Travel | 1 | 2021 | 136 | 0.160 |
Why?
| | Interferon-beta | 1 | 2020 | 92 | 0.160 |
Why?
| | Predictive Value of Tests | 4 | 2026 | 2115 | 0.160 |
Why?
| | Monte Carlo Method | 1 | 2020 | 147 | 0.160 |
Why?
| | Discriminant Analysis | 1 | 2020 | 35 | 0.150 |
Why?
| | Genome, Viral | 1 | 2021 | 214 | 0.150 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 73 | 0.150 |
Why?
| | Smoke | 2 | 2023 | 148 | 0.150 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2020 | 192 | 0.150 |
Why?
| | Decision Trees | 1 | 2020 | 78 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 264 | 0.150 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 177 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 159 | 0.150 |
Why?
| | Interferon-alpha | 1 | 2020 | 193 | 0.150 |
Why?
| | Premature Birth | 1 | 2023 | 387 | 0.150 |
Why?
| | Risk Factors | 8 | 2024 | 10857 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2023 | 409 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
| | Liver | 2 | 2019 | 1893 | 0.150 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 106 | 0.140 |
Why?
| | Rats | 4 | 2023 | 5582 | 0.140 |
Why?
| | Base Sequence | 3 | 2021 | 2168 | 0.140 |
Why?
| | Sex Characteristics | 2 | 2023 | 775 | 0.140 |
Why?
| | Air Pollution | 1 | 2022 | 312 | 0.140 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 69 | 0.140 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 19 | 0.140 |
Why?
| | Proteome | 1 | 2023 | 512 | 0.140 |
Why?
| | Reflex, Righting | 1 | 2018 | 15 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 420 | 0.140 |
Why?
| | Antiviral Agents | 2 | 2021 | 767 | 0.130 |
Why?
| | Marijuana Use | 1 | 2022 | 221 | 0.130 |
Why?
| | Receptor, Insulin | 1 | 2017 | 93 | 0.130 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2017 | 11 | 0.130 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 322 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 265 | 0.130 |
Why?
| | Epigenomics | 2 | 2018 | 112 | 0.130 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 121 | 0.130 |
Why?
| | Dendritic Cells | 1 | 2020 | 496 | 0.130 |
Why?
| | Receptors, GABA-A | 1 | 2018 | 137 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 618 | 0.120 |
Why?
| | Chemokines | 1 | 2017 | 217 | 0.120 |
Why?
| | Forced Expiratory Volume | 3 | 2026 | 450 | 0.120 |
Why?
| | Otitis Media | 1 | 2019 | 181 | 0.120 |
Why?
| | Alleles | 1 | 2019 | 888 | 0.120 |
Why?
| | Rural Population | 1 | 2021 | 657 | 0.120 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 228 | 0.120 |
Why?
| | Longevity | 1 | 2017 | 177 | 0.120 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 178 | 0.120 |
Why?
| | DNA-Binding Proteins | 3 | 2019 | 1479 | 0.120 |
Why?
| | Follow-Up Studies | 5 | 2026 | 5411 | 0.120 |
Why?
| | Keratinocytes | 1 | 2017 | 249 | 0.120 |
Why?
| | Age Factors | 2 | 2021 | 3338 | 0.120 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 500 | 0.120 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 202 | 0.120 |
Why?
| | Biomedical Research | 2 | 2020 | 717 | 0.110 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 9 | 0.110 |
Why?
| | Corpus Luteum | 1 | 2015 | 23 | 0.110 |
Why?
| | Databases, Genetic | 2 | 2021 | 238 | 0.110 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 196 | 0.110 |
Why?
| | Plasma | 1 | 2017 | 223 | 0.110 |
Why?
| | Tobacco Products | 1 | 2016 | 84 | 0.110 |
Why?
| | Granulosa Cells | 1 | 2015 | 35 | 0.110 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 73 | 0.110 |
Why?
| | Ultraviolet Therapy | 1 | 2015 | 17 | 0.110 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.110 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 560 | 0.110 |
Why?
| | Sphingomyelins | 1 | 2015 | 22 | 0.110 |
Why?
| | Vitiligo | 1 | 2015 | 42 | 0.110 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 227 | 0.110 |
Why?
| | Microarray Analysis | 2 | 2012 | 116 | 0.110 |
Why?
| | Cannabis | 1 | 2022 | 509 | 0.110 |
Why?
| | Infant, Premature | 1 | 2019 | 619 | 0.110 |
Why?
| | Obesity | 4 | 2023 | 3097 | 0.110 |
Why?
| | Hair | 1 | 2015 | 84 | 0.110 |
Why?
| | Blood Proteins | 1 | 2016 | 238 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2881 | 0.110 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 38 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1955 | 0.100 |
Why?
| | Child Development | 1 | 2019 | 483 | 0.100 |
Why?
| | Fatty Acids | 1 | 2017 | 457 | 0.100 |
Why?
| | Aged, 80 and over | 8 | 2021 | 8318 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2020 | 1127 | 0.100 |
Why?
| | STAT2 Transcription Factor | 1 | 2013 | 3 | 0.100 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 149 | 0.100 |
Why?
| | CCCTC-Binding Factor | 1 | 2013 | 12 | 0.100 |
Why?
| | Species Specificity | 2 | 2012 | 545 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 185 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 766 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 23 | 0.100 |
Why?
| | Saccharomyces | 1 | 2013 | 6 | 0.100 |
Why?
| | Caloric Restriction | 1 | 2015 | 129 | 0.100 |
Why?
| | G-Quadruplexes | 1 | 2013 | 23 | 0.100 |
Why?
| | Microbiota | 1 | 2021 | 729 | 0.100 |
Why?
| | Dietary Fats | 1 | 2015 | 308 | 0.100 |
Why?
| | Myocardium | 1 | 2018 | 931 | 0.100 |
Why?
| | Choice Behavior | 1 | 2014 | 179 | 0.090 |
Why?
| | Antitubercular Agents | 1 | 2015 | 208 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2013 | 362 | 0.090 |
Why?
| | DNA Probes | 1 | 2012 | 58 | 0.090 |
Why?
| | Programming Languages | 1 | 2012 | 24 | 0.090 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2015 | 337 | 0.090 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 139 | 0.090 |
Why?
| | Young Adult | 8 | 2026 | 14176 | 0.090 |
Why?
| | Tretinoin | 1 | 2013 | 125 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1442 | 0.090 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 384 | 0.090 |
Why?
| | Teratogens | 1 | 2012 | 25 | 0.090 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1325 | 0.090 |
Why?
| | Age of Onset | 2 | 2026 | 554 | 0.090 |
Why?
| | Weight Gain | 1 | 2015 | 561 | 0.090 |
Why?
| | Protein Binding | 2 | 2021 | 2235 | 0.080 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 76 | 0.080 |
Why?
| | Regression Analysis | 3 | 2021 | 998 | 0.080 |
Why?
| | China | 2 | 2022 | 269 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 3 | 2021 | 2767 | 0.080 |
Why?
| | Triglycerides | 2 | 2023 | 520 | 0.080 |
Why?
| | Chromosome Mapping | 3 | 2020 | 504 | 0.080 |
Why?
| | Body Weight | 1 | 2015 | 969 | 0.080 |
Why?
| | Pain Threshold | 1 | 2010 | 72 | 0.080 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 74 | 0.080 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 76 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 624 | 0.080 |
Why?
| | Dysbiosis | 2 | 2022 | 187 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 483 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2013 | 429 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2012 | 909 | 0.080 |
Why?
| | Cytokines | 1 | 2017 | 2048 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2127 | 0.070 |
Why?
| | Morphine | 1 | 2010 | 168 | 0.070 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 200 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2012 | 1300 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1039 | 0.070 |
Why?
| | Vital Capacity | 2 | 2021 | 292 | 0.070 |
Why?
| | Internet | 2 | 2010 | 689 | 0.070 |
Why?
| | Yeasts | 1 | 2008 | 50 | 0.070 |
Why?
| | Spirometry | 2 | 2021 | 233 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2015 | 933 | 0.070 |
Why?
| | Drosophila Proteins | 1 | 2010 | 212 | 0.070 |
Why?
| | Fasting | 2 | 2023 | 276 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2010 | 291 | 0.070 |
Why?
| | Food Preferences | 1 | 2009 | 126 | 0.070 |
Why?
| | Gestational Age | 2 | 2023 | 987 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 39 | 0.070 |
Why?
| | RNA Precursors | 1 | 2008 | 154 | 0.060 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 191 | 0.060 |
Why?
| | Prognosis | 2 | 2026 | 4310 | 0.060 |
Why?
| | Gene Ontology | 2 | 2017 | 53 | 0.060 |
Why?
| | Folic Acid | 2 | 2019 | 198 | 0.060 |
Why?
| | Phosphorylation | 2 | 2021 | 1706 | 0.060 |
Why?
| | Tandem Mass Spectrometry | 2 | 2021 | 571 | 0.060 |
Why?
| | Uganda | 2 | 2016 | 89 | 0.060 |
Why?
| | Glucose | 2 | 2023 | 1048 | 0.050 |
Why?
| | Neoplasms | 2 | 2018 | 2900 | 0.050 |
Why?
| | Apoptosis | 1 | 2013 | 2434 | 0.050 |
Why?
| | Sputum | 2 | 2016 | 302 | 0.050 |
Why?
| | Alkanesulfonates | 1 | 2023 | 6 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Carboxylic Acids | 1 | 2023 | 31 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 56 | 0.050 |
Why?
| | Hypertrophy | 1 | 2023 | 128 | 0.050 |
Why?
| | Privacy | 1 | 2023 | 41 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2015 | 2504 | 0.050 |
Why?
| | Models, Neurological | 1 | 2024 | 250 | 0.050 |
Why?
| | Schistosoma | 1 | 2022 | 28 | 0.050 |
Why?
| | Snails | 1 | 2022 | 38 | 0.040 |
Why?
| | Pneumonia | 2 | 2020 | 635 | 0.040 |
Why?
| | Benchmarking | 1 | 2023 | 188 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2021 | 18 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2021 | 18 | 0.040 |
Why?
| | Furin | 1 | 2021 | 12 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2023 | 2040 | 0.040 |
Why?
| | Asia | 1 | 2021 | 70 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2010 | 1145 | 0.040 |
Why?
| | Granzymes | 1 | 2022 | 49 | 0.040 |
Why?
| | Adipocytes | 1 | 2023 | 223 | 0.040 |
Why?
| | Water Resources | 1 | 2021 | 8 | 0.040 |
Why?
| | Africa | 1 | 2021 | 118 | 0.040 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.040 |
Why?
| | Nerve Net | 1 | 2024 | 284 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 119 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2021 | 69 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 54 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 85 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 406 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 102 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 145 | 0.040 |
Why?
| | Alanine | 1 | 2021 | 168 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 302 | 0.040 |
Why?
| | Europe | 1 | 2021 | 416 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 165 | 0.040 |
Why?
| | Sex Factors | 2 | 2019 | 2099 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 88 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 440 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 68 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 43 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 118 | 0.040 |
Why?
| | Cattle | 1 | 2022 | 946 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 589 | 0.040 |
Why?
| | Swine | 1 | 2022 | 822 | 0.040 |
Why?
| | Particulate Matter | 1 | 2022 | 325 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 51 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 183 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 79 | 0.040 |
Why?
| | Finland | 1 | 2019 | 78 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 118 | 0.040 |
Why?
| | Colon | 1 | 2022 | 308 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 227 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1048 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 591 | 0.040 |
Why?
| | Water | 1 | 2022 | 445 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 484 | 0.040 |
Why?
| | Computer Graphics | 1 | 2018 | 41 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2019 | 251 | 0.030 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
| | Environmental Pollution | 1 | 2018 | 20 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5886 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2578 | 0.030 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 177 | 0.030 |
Why?
| | Leptin | 1 | 2019 | 248 | 0.030 |
Why?
| | Pedigree | 1 | 2019 | 515 | 0.030 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 45 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2021 | 490 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 446 | 0.030 |
Why?
| | Maternal Health | 1 | 2018 | 50 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2017 | 23 | 0.030 |
Why?
| | Caprylates | 1 | 2017 | 19 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 455 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 63 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 92 | 0.030 |
Why?
| | United States | 3 | 2021 | 16065 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 441 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 112 | 0.030 |
Why?
| | Gambia | 1 | 2016 | 8 | 0.030 |
Why?
| | Time Factors | 2 | 2021 | 7107 | 0.030 |
Why?
| | THP-1 Cells | 1 | 2016 | 19 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 454 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2016 | 36 | 0.030 |
Why?
| | Lod Score | 1 | 2016 | 62 | 0.030 |
Why?
| | Regulon | 1 | 2016 | 34 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 834 | 0.030 |
Why?
| | Actins | 1 | 2018 | 424 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 46 | 0.030 |
Why?
| | Child Health | 1 | 2018 | 153 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2017 | 207 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 765 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 97 | 0.030 |
Why?
| | ABO Blood-Group System | 1 | 2016 | 56 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2133 | 0.030 |
Why?
| | Fetal Development | 1 | 2019 | 298 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1244 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 250 | 0.030 |
Why?
| | Follicular Phase | 1 | 2015 | 41 | 0.030 |
Why?
| | Ovulation | 1 | 2015 | 46 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 17 | 0.030 |
Why?
| | Mice, Congenic | 1 | 2015 | 23 | 0.030 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2017 | 207 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 43 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 104 | 0.030 |
Why?
| | Immune System | 1 | 2016 | 177 | 0.030 |
Why?
| | Hair Follicle | 1 | 2015 | 49 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 65 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2855 | 0.030 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 70 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 72 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 537 | 0.030 |
Why?
| | Heart | 1 | 2018 | 626 | 0.030 |
Why?
| | Breeding | 1 | 2014 | 63 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 378 | 0.030 |
Why?
| | Protein Kinases | 1 | 2016 | 312 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 804 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2017 | 236 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 156 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 326 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 266 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1066 | 0.020 |
Why?
| | Monophenol Monooxygenase | 1 | 2013 | 7 | 0.020 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2013 | 17 | 0.020 |
Why?
| | Annexin A5 | 1 | 2013 | 23 | 0.020 |
Why?
| | Melanins | 1 | 2013 | 16 | 0.020 |
Why?
| | Spectrophotometry | 1 | 2013 | 58 | 0.020 |
Why?
| | Education | 1 | 2013 | 104 | 0.020 |
Why?
| | Catalase | 1 | 2013 | 134 | 0.020 |
Why?
| | Administration, Topical | 1 | 2013 | 153 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 387 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1889 | 0.020 |
Why?
| | Blood Glucose | 1 | 2023 | 2335 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 427 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1244 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 337 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 563 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 688 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 307 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 258 | 0.020 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 17 | 0.020 |
Why?
| | Receptors, GABA | 1 | 2010 | 13 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 17 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 12 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 25 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1163 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 123 | 0.020 |
Why?
| | Cell Movement | 1 | 2015 | 959 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 171 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1100 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 308 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4538 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1763 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 955 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2016 | 962 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2009 | 321 | 0.020 |
Why?
| | Antioxidants | 1 | 2013 | 550 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2009 | 117 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 194 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1197 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1500 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1597 | 0.020 |
Why?
| | Histones | 1 | 2013 | 665 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 534 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6055 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 1067 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3539 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2013 | 4142 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2207 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4552 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17247 | 0.010 |
Why?
|
|
Kechris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|